Open-Label Surufatinib in European Patients With NET
Stopped early · Phase 2
Conditions studied: Neuroendocrine Tumours, Neuroendocrine Tumour of the Lung, Small Intestinal NET
In brief
This is a Phase 2, open-label, multi-centre study of surufatinib in patients with low to intermediate grade (Grade 1 or Grade 2), well-differentiated neuroendocrine tumours (NETs).
Key facts
- Study ID
- NCT04579679
- Run by
- Hutchmed
- People needed
- 78
- Starts
- 2021-08-13
- Expected to finish
- 2024-10-15
- Last updated by the study team
- 2025-07-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama, Birmingham (UAB) — Birmingham, Alabama, United States
- University of California Irvine Medical Center UCIMC - H.H. Chao Comprehensive Digestive Disease Center CDDC — Orange, California, United States
- Emory University, Winship Cancer Institute — Atlanta, Georgia, United States
- Stony Brook Cancer Center — Stony Brook, New York, United States
- Houston Methodist — Houston, Texas, United States
- CHU Bordeaux — Pessac, France
- Institut Gustave Roussy — Villejuif, France
- Charite Universitatsmedizin Berlin — Berlin, Germany
- Universitaetsklinikum Erlangen — Erlangen, Germany
- Universitatsklinikum Essen, Klinik fur Endokrinologie — Essen, Germany
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari — Bari, Italy
- ASST-Spedali Civili di Brescia — Brescia, Italy
- Universita degli Studi di Firenze - Azienda Ospedaliero Universitaria Careggi (AOUC) — Florence, Italy
- Istituto Europeo di Oncologia — Milan, Italy
- Haukeland University Hospital — Bergen, Norway
- Oslo University Hospital Rikshospitalet — Oslo, Norway
- Institut Catala d'Oncologis (ICO) - Hospital Duran i Reynals — Barcelona, Spain
- Hospital Vall Hebron — Barcelona, Spain
- Hospital Universitario Ramon y Cajal — Madrid, Spain
- Hospital Universitario 12 de Octubre — Madrid, Spain
- Hospital Universitario Virgen del Rocio — Seville, Spain
- Sarah Cannon Research Institute — London, United Kingdom
- Christie Hospital — Manchester, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.